欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2003, Vol. 8 ›› Issue (3): 348-350.

• 研究原著 • 上一篇    下一篇

丁咯地尔治疗椎-基底动脉缺血临床疗效评价

杨天宏, 杨丽莉1, 胡太国   

  1. 孟州市中医院骨科, 孟州 454750, 河南; 1孟州市第二人民医院内科, 孟州 454750, 河南
  • 收稿日期:2002-09-18 修回日期:2003-01-15 出版日期:2003-06-26 发布日期:2020-11-25
  • 通讯作者: 杨天宏, 男, 主治医师, 主要从事骨关节退行性疾病研究。Tel:0391-8161871

Evaluation of clinical efficacy of buflomedil in treatment of patients with ventebro basilar ischemia

YANG Tian-Hong, YANG Li-Li1, HU Tai-Guo   

  1. Department of Osteology, Mengzhou Traditional Chinese Medicine Hospital, Mengzhou 454750, Henan; 1Department of Cardiology, Mengzhou Second People's Hospital, Mengzhou 454750, Henan
  • Received:2002-09-18 Revised:2003-01-15 Online:2003-06-26 Published:2020-11-25

摘要: 目的: 探讨丁咯地尔对椎基底动脉缺血的治疗作用。方法: 将92 例椎基底动脉缺血患者随机分为丁咯地尔组(46 例) 和盐酸培他啶组(46 例), 逐日观察疗效。结果: 丁咯地尔组临床效果显著, 用药治疗72 h 后总有效率96. 6 %。结论: 丁咯地尔治疗椎基底动脉缺血疗效好, 起效快, 具有临床应用价值。

关键词: 药效学, 丁咯地尔, 椎基底动脉缺血

Abstract: AIM: To examine the effects of buflomedil in treatment of patients with ventebro basilar ischemia. METHODS: 92 case of patients with ventebro basilar ischemia were randomly divided into two groups: buflomedil group and control group. The curative effects were observed daily. RESULTS: The total clinical effective rate were 96. 6 %in 72 hours. CONCLUSION: Buflomedil is an effective agent in the treatment of patients with ventebro basilar ischemia.

Key words: pharmacodynamics, buflomedil, ventebro basilar ischemia

中图分类号: